Sep 30, 2024
1:8
For every 8 shares held, investors received 1. The price per share adjusted from $0.84 to $0.10.
The split itself did not change the total investment value.
Sonnet BioTherapeutics Holdings, Inc. (SONN) trades on the NASDAQ Capital Market in the Biotechnology industry.
Sonnet BioTherapeutics Holdings, Inc. company overviewThe latest split shown was on September 30, 2024. It was a 1-for-8 reverse split, so shareholders received 1 share for every 8 they held.
This history records 8 splits between July 17, 2008 and September 30, 2024.